BNTC
Benitec Biopharma Inc.NASDAQHealthcare$10.92+0.64%ClosedMarket Cap: $286.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.70
P/S
518.80
EV/EBITDA
-1.96
DCF Value
$2.67
FCF Yield
-6.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
-11.9%
Operating Margin
-9090.6%
Net Margin
-8327.9%
ROE
-38.9%
ROA
-24.3%
ROIC
-26.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $0.00 | -Infinity% | $-13.4M | $-11.8M | $-0.26 | — |
| Q1 2026 | $0.00 | -Infinity% | $-9.8M | $-9.0M | $-0.22 | — |
| Q4 2025 | $556.0K | 50.0% | $-17.2M | $-16.1M | $-0.39 | — |
| FY 2025 | $0.00 | -Infinity% | $-41.8M | $-37.9M | $-1.05 | — |
| Q3 2025 | $0.00 | -Infinity% | $-10.2M | $-9.4M | $-0.24 | — |
| Q2 2025 | $0.00 | -Infinity% | $-8.6M | $-7.4M | $-0.33 | — |
| Q1 2025 | $0.00 | -Infinity% | $-5.8M | $-5.1M | $-0.48 | — |
| Q4 2024 | $0.00 | -Infinity% | $-5.5M | $-4.7M | $-0.53 | — |
| FY 2024 | $0.00 | -Infinity% | $-22.6M | $-21.8M | $-2.68 | — |
| Q3 2024 | $0.00 | -Infinity% | $-4.1M | $-4.3M | $-0.23 | — |
| Q2 2024 | $0.00 | -Infinity% | $-6.9M | $-6.8M | $-1.32 | — |
| Q1 2024 | $0.00 | Infinity% | $-5.9M | $-6.0M | $-1.38 | — |